Actions
Pages
Subscribe for newsletter
Stories
The Tokyo Stock Exchange (TSE) has introduced a market maker mechanism trial to invigorate their carbon credit trading market. The mechanism is designed to ensure liquidity by making companies quote a certain volume of buy and sell orders within a price range.
As the world's fifth-largest carbon emitter, Japan is using the carbon credit market strategy to combat climate change. In April, Japan initiated a gradual implementation of a carbon pricing scheme aimed at motivating companies and cities to reduce their emissions in hopes for the country to become carbon neutral by 2050.
Leading global bank, Mizuho Financial Group, has invested in Climate Impact X (CIX), a Singapore-based carbon credit marketplace, to expand the carbon credit market in Asia. The partnership focuses on expanding carbon credit accessibility and reliability, leveraging CIX's advanced technology like satellite monitoring, machine learning, and blockchain to ensure transparency and integrity in carbon trading.
The trial will be a litmus test for the market's viability and could set a precedent for similar initiatives globally.
Japan's cautious approach, contrasting with aggressive carbon pricing in other Asian markets, reflects its unique economic and environmental challenges.
Critics argue that without a compliance market, Japan's carbon credit market may struggle to gain significant traction.
Story
Sanofi has entered into a partnership with Aqemia, a Paris-based startup specializing in quantum physics algorithms and generative AI for drug discovery. Sanofi plans to use Aqemia’s, spun out of École normale supérieure in 2019, tech to discover small molecules in various therapeutic areas.
The $140 million collaboration taps into the booming AI drug discovery market expected to reach $15.44 billion by 2032, ushering a new era of faster, more effective drug development.
“This whole new step is about scaling our respective expertise to multiple projects and supporting Sanofi in discovering novel chemical matter at scale with our unique technology – including on difficult projects with limited chemical data upfront and hard issues like selectivity,” said Maximilien Levesque, Aqemia CEO and Co-founder.
Sanofi continues to push the boundaries of drug discovery with more AI acquisitions.
Story
Wormhole, a leading blockchain communication network, has raised $225 million in funding at a $2.5 billion valuation. It has launched Wormhole Labs which will focus on developing advanced cross-chain technology.
The development of Wormhole Labs emphasizes the increasing importance of advancing cross-chain interactions, making transactions more convenient and efficient. This is crucial for Web3 growth and a wide range of blockchain applications.
"We're laser-focused on bringing solutions to market that solve real problems for our customers and end-users, and are on a mission to enable real-world impact from the Web3 space," - Robinson Burkey, Wormhole Foundation’s Chief Commercial Officer.
Wormhole's trajectory suggests an aggressive expansion into new blockchain technologies and potential partnerships with major industry players.
Wormhole’s growth suggests a growing acceptance and integration of blockchain technology in mainstream markets, defying skepticism about its practical applications and long-term viability.
Story
Innovators
Scroll
Open
Close